UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Parisi Gray Wealth Management

Parisi Gray Wealth Management reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 10.6% during the 4th quarter, HoldingsChannel.com reports. The fund owned 6,068 shares of the healthcare conglomerate’s stock after selling 717 shares during the quarter. UnitedHealth Group accounts for 1.0% of Parisi Gray Wealth Management’s portfolio, making the stock its 26th largest position. Parisi Gray Wealth Management’s holdings in UnitedHealth Group were worth $3,069,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Hanson & Doremus Investment Management boosted its holdings in UnitedHealth Group by 10.9% during the 2nd quarter. Hanson & Doremus Investment Management now owns 459 shares of the healthcare conglomerate’s stock valued at $234,000 after acquiring an additional 45 shares during the period. Retirement Planning Co of New England Inc. grew its holdings in shares of UnitedHealth Group by 5.4% in the second quarter. Retirement Planning Co of New England Inc. now owns 448 shares of the healthcare conglomerate’s stock valued at $228,000 after purchasing an additional 23 shares in the last quarter. WINTON GROUP Ltd acquired a new stake in UnitedHealth Group during the 2nd quarter worth approximately $228,000. Fairfield Financial Advisors LTD acquired a new position in shares of UnitedHealth Group in the second quarter worth $2,194,000. Finally, Capital Wealth Planning LLC boosted its holdings in UnitedHealth Group by 4.1% in the second quarter. Capital Wealth Planning LLC now owns 1,016,952 shares of the healthcare conglomerate’s stock valued at $517,893,000 after purchasing an additional 39,713 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Truist Financial decreased their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. UBS Group dropped their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Piper Sandler dropped their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Stephens upped their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Finally, Barclays boosted their target price on UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 27th. Two investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average target price of $626.79.

UnitedHealth Group Stock Up 4.0 %

Shares of NYSE UNH opened at $541.28 on Tuesday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The stock has a market capitalization of $498.13 billion, a price-to-earnings ratio of 35.26, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62. The firm has a 50-day moving average price of $554.92 and a 200 day moving average price of $562.88. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter in the previous year, the company posted $6.56 EPS. The business’s revenue was up 9.2% on a year-over-year basis. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.